FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hitoshi Hori

Research Profile

Disorders

Squamous Cell Carcinoma

Chemicals & Drugs

Living Beings

Procedures

Physiology

Phenomena

Gamma Rays

Anatomy

Chromosome-Defective Micronucleus

Co-author Network

Publications

TOP 3
Ryosuke Munakata; Kanako Sasaki; Akifumi Sugiyama; Yusuke Tsurumaru; Yoshihiro Uto; Jun-Ichi Azuma; Hitoshi Hori; Tsuyoshi Inoue; Takao Koeduka; Kazufumi Yazaki
Characterization of coumarin-specific prenyltransferase activities in Citrus limon peel.
Shin-Ichiro Masunaga; Hideko Nagasawa; Kenji Nagata; Minoru Suzuki; Yoshihiro Uto; Hitoshi Hori; Yuko Kinashi; Koji Ono
Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.
Shin-Ichiro Masunaga; Yoshinori Sakurai; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori; Koji Ono
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hitoshi Hori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ryosuke Munakata; Kanako Sasaki; Akifumi Sugiyama; Yusuke Tsurumaru; Yoshihiro Uto; Jun-Ichi Azuma; Hitoshi Hori; Tsuyoshi Inoue; Takao Koeduka; Kazufumi Yazaki
Characterization of coumarin-specific prenyltransferase activities in Citrus limon peel.
Bioscience, biotechnology, and biochemistry 2012;76(7):1389-93.
2007: Shin-Ichiro Masunaga; Hideko Nagasawa; Kenji Nagata; Minoru Suzuki; Yoshihiro Uto; Hitoshi Hori; Yuko Kinashi; Koji Ono
Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.
Journal of cancer research and clinical oncology 2007;133(1):47-55.
2006: Shin-Ichiro Masunaga; Yoshinori Sakurai; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori; Koji Ono
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
The British journal of radiology 2006;79(948):991-8.
2006: Shin-Ichiro Masunaga; Hideko Nagasawa; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2006;22(4):287-99.
2006: Shin-Ichiro Masunaga; Yoshihiro Uto; Hideko Nagasawa; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Yuko Kinashi; Koji Ono
Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Anticancer research 2006;26(2A):1261-70.
2006: Shin-Ichiro Masunaga; Hideko Nagasawa; Keiko Gotoh; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Radiation medicine 2006;24(2):98-107.
2005: Shin-Ichiro Masunaga; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori; Ken Ohnishi; Akihisa Takahashi; Takeo Ohnishi; Minoru Suzuki; Kenji Nagata; Yuko Kinashi; Koji Ono
Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
Oncology reports 2005;14(2):393-400.
2005: Shin-Ichiro Masunaga; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori; Minoru Suzuki; Kenji Nagata; Yuko Kinashi; Koji Ono
The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2005;21(4):305-18.
2004: Shin-Ichiro Masunaga; Hideko Nagasawa; M Hiraoka; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2004;61(5):953-8.
2004: Shin-Ichiro Masunaga; Hideko Nagasawa; Masamitsu Hiraoka; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Anticancer research 2004;24(5A):2975-83.
2003: Shin-Ichiro Masunaga; Koji Ono; Akihisa Takahashi; Ken Ohnishi; Takeo Ohnishi; Minoru Suzuki; Kenji Nagata; Yuko Kinashi; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Cancer science 2003;94(1):125-33.
2003: Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Tooru Kobayashi; Minoru Suzuki; Kenji Nagata; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
Journal of cancer research and clinical oncology 2003;129(1):21-8.
2001: Shin-Ichiro Masunaga; Koji Ono; Mitsunori Kirihata; Masao Takagaki; Yoshinori Sakurai; Yuko Kinashi; Toru Kobayashi; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Japanese journal of cancer research : Gann 2001;92(9):996-1007.
2001: Shin-Ichiro Masunaga; Koji Ono; Minoru Suzuki; Yasumasa Nishimura; Yuko Kinashi; Masao Takagaki; Hitoshi Hori; Hideko Nagasawa; Yoshihiro Uto; I Tsuchiya; S Sadahiro; Chieko Murayama
Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
International journal of radiation oncology, biology, physics 2001;50(4):1063-72.
2000: Shin-Ichiro Masunaga; Koji Ono; Minoru Suzuki; Yuko Kinashi; Masao Takagaki; S Kasai; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration.
Japanese journal of cancer research : Gann 2000;91(7):731-6.
2000: Shin-Ichiro Masunaga; Koji Ono; Yasumasa Nishimura; S Kanamori; T Saga; Minoru Suzuki; Yuko Kinashi; Masao Takagaki; S Kasai; Hideko Nagasawa; Yoshihiro Uto; Hitoshi Hori
Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
International journal of radiation oncology, biology, physics 2000;47(3):799-807.
2000: Shin-Ichiro Masunaga; Koji Ono; Minoru Suzuki; Yuko Kinashi; Masao Takagaki; Hitoshi Hori; S Kasai; Hideko Nagasawa; Yoshihiro Uto
Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
Japanese journal of cancer research : Gann 2000;91(5):566-72.
1999: Shin-Ichiro Masunaga; Koji Ono; Hitoshi Hori; Minoru Suzuki; Yuko Kinashi; Masao Takagaki; S Kasai; Hideko Nagasawa; Yoshihiro Uto
Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
Radiation medicine 1999;17(4):259-64.
1999: Shin-Ichiro Masunaga; Koji Ono; Hitoshi Hori; Yuko Kinashi; Minoru Suzuki; Masao Takagaki; S Kasai; Hideko Nagasawa; Yoshihiro Uto
Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1999;15(1):7-16.
1998: Shin-Ichiro Masunaga; Koji Ono; Hitoshi Hori; M Akaboshi; K Kawai; Minoru Suzuki; Yuko Kinashi; S Kasai; Hideko Nagasawa; Yoshihiro Uto
Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Radiation medicine 1998;16(6):441-8.
1998: Shin-Ichiro Masunaga; Koji Ono; Yoshinori Sakurai; Hitoshi Hori; Toru Kobayashi; Masao Takagaki; Minoru Suzuki; Yuko Kinashi; M Akaboshi
Applicability of combination with tirapazamine in boron neutron capture therapy.
Japanese journal of cancer research : Gann 1998;89(7):768-74.
1990: Keisuke Sasai; Yuta Shibamoto; M Takahashi; L Zhou; Hitoshi Hori; H Nagasawa; Toru Shibata; S Inayama; M Abe
KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
Cancer chemotherapy and pharmacology 1990;26(2):112-6.